GlassScriptPhysician profile
Vinay Patel
NPI 1568621407
$9,530.13
in general payments reported to CMS, 2019-2025
34 companies · $1,092 in 2025
The $1,092 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $71.06 · 2021: $613 · 2022: $2,746 · 2023: $1,352 · 2024: $3,418 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,890 · Travel and Lodging: $929 · Gift: $23.40 · Consulting Fee: $19.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,890.27 |
| Travel and Lodging | $928.74 |
| Gift | $23.40 |
| Consulting Fee | $19.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,506.26 | 2024-2025 | |
| Pulmonx Corporation | $1,416.59 | 2022-2024 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Ethicon INC. | $1,302.23 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $999.95 | 2021-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $779.11 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Grifols USA, LLC | $401.70 | 2023-2024 | Prolastin-C Liquid |
| Inogen, INC. | $334.49 | 2024-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Insmed, INC. | $290.78 | 2020-2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $272.05 | 2022-2024 | Dupixent |
| Mallinckrodt Hospital Products INC. | $201.69 | 2021-2023 | Acthar |
| Amgen INC. | $200.86 | 2022-2025 | Tezspire, Uplizna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.31 | 2021-2025 | Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $178.19 | 2025 | Cuvitru, Glassia, Gattex |
| Genentech USA, INC. | $159.78 | 2019-2022 | |
| Inari Medical, INC. | $152.98 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $148.30 | 2022-2023 | Illumisite |
| Merck Sharp & Dohme LLC | $136.57 | 2022-2025 | Zerbaxa, Dificid, Zinplava |
| Baxter Healthcare | $127.78 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2022 | |
| Phathom Pharmaceuticals, INC. | $113.30 | 2024-2025 | Voquezna |
| Genzyme Corporation | $84.23 | 2023-2025 | |
| Verona Pharma, INC. | $66.44 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $47.37 | 2024 | Watchman Flx |
| Philips North America LLC | $40.79 | 2025 | Vest Therapy Und |
| Ceribell, INC. | $36.00 | 2023 | Ceribell Rapid Response Eeg |
| Madrigal Pharmaceuticals | $32.38 | 2024 | Resmetirom |
| Vapotherm INC | $28.77 | 2022 | |
| United Therapeutics Corporation | $28.69 | 2023 | Tyvaso |
| Pfizer INC. | $26.85 | 2025 | |
| Paratek Pharmaceuticals, INC. | $24.34 | 2022 | |
| Tempus Ai, INC | $23.34 | 2025 | Xt Cdx |
| Electromed, INC. | $19.44 | 2024 | Smartvest |
| Adma Biomanufacturing LLC | $19.40 | 2024 | |
| Janssen Biotech, INC. | $18.18 | 2024 | Rybrevant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.